Biophysical and biochemical investigations of dsRNA-activated kinase PKR

被引:14
|
作者
McKenna, Sean A. [1 ]
Lindhout, Darrin A.
Shimoike, Takashi
Puglisi, Joseph D.
机构
[1] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA
[2] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan
[3] Stanford Univ, Sch Med, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA
关键词
D O I
10.1016/S0076-6879(07)30014-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase RNA-activated (PKR) is a serine/threonine kinase that contains an N-terminal RNA-binding domain (dsRNA) and a C-terminal kinase domain. On binding viral dsRNA molecules, PKR can become activated and phosphorylate cellular targets, such as eukaryotic translation initiation factor 2 alpha (elF-2 alpha). Phosphorylation of eIF-2 alpha results in attenuation of protein translation initiation. Therefore, PKR plays an integral role in the antiviral response to cellular infection. Here we provide a methodological framework for probing PKR function by use of assays for phosphorylation, RNA-protein stability, PKR dimerization, and in vitro translation. These methods are complemented by nuclear magnetic resonance approaches for probing structural features of PKR activation. Considerations required for both PKR and dsRNA sample preparation are also discussed.
引用
收藏
页码:373 / 396
页数:24
相关论文
共 50 条
  • [1] THE ROLE OF THE DSRNA-ACTIVATED KINASE, PKR, IN SIGNAL-TRANSDUCTION
    WILLIAMS, BRG
    SEMINARS IN VIROLOGY, 1995, 6 (03): : 191 - 202
  • [2] Anti RSV immunoglobulin isotype selection requires dsRNA-activated protein kinase (PKR)
    Minor, Radiah Ann Corn
    Croom, Brittany
    Imani, Farhad
    FASEB JOURNAL, 2008, 22
  • [3] Overexpression of dsRNA-activated protein kinase (PKR) in the liver with chronic hepatitis C.
    Yu, SH
    Enomoto, N
    Nagayama, K
    Kurosaki, M
    Sato, C
    HEPATOLOGY, 1999, 30 (04) : 359A - 359A
  • [4] A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR
    Wu, SY
    Kaufman, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1291 - 1296
  • [5] Novel inhibitors of the interferon-inducible, dsRNA-activated kinase PKR for myelodysplastic syndrome.
    Bennett, Richard L.
    Ostrov, David A.
    May, W. Stratford
    CANCER RESEARCH, 2013, 73 (08)
  • [6] Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome
    Sud, Neetu
    Rutledge, Angela C.
    Pan, Kaichao
    Su, Qiaozhu
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (18) : 2697 - 2703
  • [7] Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells
    Savinova, O
    Joshi, B
    Jagus, R
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (01): : 175 - 189
  • [8] Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin
    Bennett, Richard L.
    Carruthers, Aubrey L.
    Hui, Teng
    Kerney, Krystal R.
    Liu, Xiangfei
    May, W. Stratford, Jr.
    PLOS ONE, 2012, 7 (09):
  • [9] MUTATIONAL ANALYSIS OF THE DOUBLE-STRANDED-RNA (DSRNA) BINDING DOMAIN OF THE DSRNA-ACTIVATED PROTEIN-KINASE, PKR
    MCMILLAN, NAJ
    CARPICK, BW
    HOLLIS, B
    TOONE, WM
    ZAMANIANDARYOUSH, M
    WILLIAMS, BRG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2601 - 2606
  • [10] trans-autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR
    Wu, SY
    Kaufman, RJ
    BIOCHEMISTRY, 2004, 43 (34) : 11027 - 11034